Arrhythmias & electrophysiology

Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study

Eur Heart J Qual Care Clin OutcomesPublished Retrospective cohort study

Authors' conclusion

DOAC use, compared with warfarin use, was associated with a lower or similar risk of all-cause death, ischaemic stroke, and transient ischaemic attack and also a lower or similar risk of major bleeding across all levels of kidney function.

Study context

Population
Adults with AF and a baseline estimated glomerular filtration rate (eGFR), Australia and Canada, 2011–18matched analysis
Participants
74,542 adults
Exposure
DOAC vs warfarin, by eGFR category
Outcome
Composite of all-cause death, first hospitalization for ischaemic stroke or TIA (effectiveness); first hospitalization for major bleeding (safety)
Follow-up
Within 1 year from cohort entry
Methodological detailspooled analysis of five cohorts, propensity-score matched (1:1), multicentre
  • Pooled analysis of five cohorts
  • Propensity-score matched (1:1)
  • Multicentre

Main finding

As reported in the abstract

All-cause death, ischaemic stroke or TIA, by eGFR (mL/min/1.73 m²) · 1 year
DOAC vs WarfarinPooled hazard ratio (95% CI)
eGFR ≥60
0.74(0.69–0.79)
eGFR 45-59
0.76(0.54–1.07)
eGFR 30-44
0.68(0.61–0.75)
eGFR <30
0.86(0.76–0.98)

Observational data: associations, not effects.

Safety

OutcomePooled HR (95% CI)
Major bleeding (intracranial, GI or other), by eGFR (mL/min/1.73 m²) · 1 yearDOACvs WarfarineGFR ≥60 · matched cohort0.75 (0.65–0.86)
Major bleeding (intracranial, GI or other), by eGFR (mL/min/1.73 m²) · 1 yearDOACvs WarfarineGFR 45-59 · matched cohort0.81 (0.65–1.01)
Major bleeding (intracranial, GI or other), by eGFR (mL/min/1.73 m²) · 1 yearDOACvs WarfarineGFR 30-44 · matched cohort0.82 (0.66–1.02)
Major bleeding (intracranial, GI or other), by eGFR (mL/min/1.73 m²) · 1 yearDOACvs WarfarineGFR <30 · matched cohort0.71 (0.52–0.99)

Original publication

Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study. Eur Heart J Qual Care Clin Outcomes. Published 27 October 2022. doi:10.1093/ehjqcco/qcac069

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.